gvtcx

VDPS Medical Assessments

NHS Business Services Authority Published 3 Mar 2026 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£30,000,000 (£36,000,000 inc. VAT)
Statuscomplete
Category (CPV) 85120000 +5 more
Deadline30 Jun 2025
Procedureopen
SME suitableYes
OCIDocds-h6vhtk-04f997

Award

SupplierValueDateStatus
Maximus UK Services Limited £22,562,500 22 Dec 2025 active

description

The Authority requires the provision of medical assessments in relation to the Vaccine Damage Payment Scheme (VDPS). Further information on the scheme can be found here https://www.gov.uk/vaccine-damage-payment/eligibility

The services required are for Medical Assessments of the evidence being presented by applicants making a claim under the VDPS. An ‘Assessment’ is the end-to-end process to assess causation and level of disablement against the medical evidence presented in relation to a Claimant’s health condition and/or disability.

The Supplier is required to undertake all appropriate action to complete the assessment. This may include gathering evidence from the most appropriate source, reference, expert, and/or specialist to ensure a definitive view can be provided.

The Total Contract Value (Estimated) includes the 2 x 12 month extension periods and excludes any payments to be made to claimants.

The scope and value of the contract may be directly impacted by a number of risks which may materialise during the term of the contract. These include:

  1. The variable volume and complexity of claims received by the NHSBSA under the VDPS which require assessment. The volume of claims and subsequently the scope and value of the contract may be impacted as a result and may increase or decrease the estimated scope and contract value stated at the time of publishing the Tender Notice, commencing the procurement process or at Contract Award Stage.

2.Volumes can be impacted by a combination of external factors which the NHSBSA cannot fully control, eg. media coverage, addition of new diseases, and therefore vaccinations, to the Scheme.

3.Future Policy changes and/or changes to the Vaccine Damage Payments Act 1979 may ultimately impact how the services may be are delivered by the supplier e.g. impact on claims volumes and/or requirements.

  1. The completion of the Implementation Period is expected to take 6 months to 12 months. The value and scope of the number of assessments completed over the remaining term of the contract may therefore be impacted by the duration of the implementation period.
  2. Impacted following another pandemic or increased roll out of vaccines where the vaccine is on VDPS.
  3. Changes that come out as recommendations of the Covid Inquiry.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

8 notices published against this procurement.

PublishedTypeRegimeNotice
3 Nov 2021 Planning (planning) · e393ccb2-d040-41e3-8f86-2740074efe96-482435
25 Sept 2023 Prior information notice (F01) Earlier regulations 028151-2023
27 Mar 2025 Planned procurement (UK3) Procurement Act 2023 011589-2025
20 May 2025 Pipeline notice (UK1) Procurement Act 2023 022908-2025
20 May 2025 Pipeline notice (UK1) Procurement Act 2023 022909-2025
4 Jun 2025 Tender notice (UK4) Procurement Act 2023 030049-2025
5 Jan 2026 Contract award (UK6) Procurement Act 2023 000373-2026
3 Mar 2026 Contract details (UK7) Procurement Act 2023 018732-2026

more from NHS Business Services Authority

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.